Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21916,193,2.18 [1.67-2.86],1.5365492443008975e-08
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23129,250,1.73 [1.36-2.20],8.880239679275938e-06
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22851,1764,1.89 [1.72-2.07],7.523701945777707e-42
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23136,551,1.85 [1.57-2.18],1.476851454462867e-13
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22377,4241,1.67 [1.57-1.78],1.1346613375556358e-59
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22314,4320,1.93 [1.82-2.05],6.971183655446457e-101
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22844,1436,1.85 [1.67-2.05],9.401973366368196e-32
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23039,129,2.31 [1.68-3.19],2.631536045448032e-07
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20296,1301,2.43 [2.18-2.70],2.269485949619695e-58
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19591,1591,2.76 [2.52-3.03],5.777528595075161e-100
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19081,342,3.40 [2.77-4.17],1.2228994635622643e-31
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15066,2760,1.94 [1.80-2.09],5.2241817165153846e-67
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19028,501,3.34 [2.82-3.95],1.0176900140005252e-44
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23114,1706,1.79 [1.62-1.96],1.9720785026572905e-33
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23230,645,1.84 [1.58-2.14],2.0396562351517946e-15
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22341,1254,1.97 [1.77-2.20],3.552443261514974e-35
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23157,1434,2.10 [1.90-2.32],4.366460199427271e-49
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21658,250,1.82 [1.43-2.33],1.6265753876097822e-06
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23290,68,2.09 [1.32-3.32],0.0016265290003424
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22978,1255,2.12 [1.90-2.35],1.1149491558311613e-43
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22990,80,1.05 [0.66-1.67],0.8434254416643693
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23225,143,1.64 [1.19-2.26],0.0026891022875689
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23201,119,1.63 [1.14-2.33],0.0070826709469778
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21592,505,2.38 [2.02-2.80],7.7944325337040765e-25
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21396,309,2.11 [1.69-2.63],4.7531598909517616e-11
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21547,139,2.39 [1.75-3.27],4.695192973248047e-08
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23275,51,2.26 [1.41-3.62],0.00071913353228
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23222,174,1.53 [1.14-2.07],0.0050547612579459
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23103,55,1.14 [0.65-2.01],0.641107816621403
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23127,79,2.14 [1.42-3.21],0.0002498723567258
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm,22996,264,0.86 [0.66-1.12],0.2495894406050929
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23206,39,0.85 [0.43-1.70],0.6484559033259354
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23189,42,0.78 [0.40-1.52],0.4658091340954676
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11113,85,0.82 [0.52-1.31],0.4174913255970081
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22819,1679,1.06 [0.95-1.17],0.3059663401436999
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of meninges,23273,66,2.14 [1.36-3.37],0.0010459011516898
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23195,78,2.06 [1.36-3.11],0.0006264121740786
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23262,117,1.46 [1.01-2.11],0.0422711142214347
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of ovary,12108,79,1.01 [0.62-1.64],0.96712464533756
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23250,443,1.21 [0.99-1.47],0.0604619322297543
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23257,385,1.08 [0.87-1.34],0.4920558050126223
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23139,86,0.91 [0.58-1.44],0.6904530366013295
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23246,255,0.95 [0.72-1.23],0.6781919649905499
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23204,412,1.00 [0.81-1.23],0.9900984816394915
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23134,679,0.99 [0.85-1.17],0.9427761346498214
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23232,544,1.14 [0.96-1.36],0.1455276040322872
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Carcinoma in situ of breast,9110,50,1.23 [0.67-2.26],0.496249022356709
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9154,67,1.08 [0.64-1.84],0.7734955480992876
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16630,72,1.31 [0.80-2.15],0.2773958058643516
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16658,100,1.56 [1.04-2.33],0.0314706236307969
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23233,125,1.33 [0.92-1.92],0.1289735735113964
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Haemangioma, any site",23234,122,1.30 [0.90-1.89],0.1607648777276401
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Leiomyoma of uterus,11839,167,1.07 [0.77-1.50],0.6703970943691973
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Lung cancer and mesothelioma,14737,482,1.58 [1.30-1.91],3.0505786688957583e-06
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Lymphoid leukaemia,16631,73,1.33 [0.82-2.17],0.2531571480871019
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16786,228,1.17 [0.88-1.56],0.271492201922556
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16880,322,1.06 [0.83-1.34],0.6447883980843261
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9233,104,1.16 [0.76-1.75],0.4970620866192209
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16665,107,1.13 [0.75-1.70],0.571154921949891
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16704,146,1.61 [1.15-2.24],0.0052075632812629
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16681,123,1.40 [0.97-2.03],0.0724081601631485
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9217,88,1.10 [0.70-1.74],0.6724024603662987
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16685,127,1.11 [0.76-1.63],0.5816281130497973
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8414,985,1.16 [1.01-1.33],0.029745563366998
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16696,138,0.68 [0.47-1.00],0.0505952080312537
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16650,92,1.12 [0.72-1.74],0.6086080480951055
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16703,145,1.45 [1.02-2.05],0.0375845672612449
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Melanocytic naevi,23146,185,1.05 [0.77-1.43],0.7776362656094264
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23262,78,0.99 [0.62-1.60],0.9826707281891306
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Melanoma in situ,16611,112,0.96 [0.64-1.46],0.8620587320966657
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16680,122,1.78 [1.24-2.54],0.0016078987722025
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16757,199,1.75 [1.32-2.32],9.726965965087688e-05
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16888,330,1.19 [0.94-1.49],0.143354368877228
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16686,128,2.40 [1.74-3.33],1.3021334996663328e-07
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Other benign neoplasms of skin,23115,164,1.09 [0.79-1.51],0.5978248778043774
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18055,1497,1.22 [1.09-1.36],0.0003343453103868
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18141,1583,1.20 [1.08-1.33],0.0008523654628568
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22984,394,1.47 [1.21-1.80],0.000151311620013
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20955,168,7.64 [6.23-9.36],2.0180316554199545e-85
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22659,69,3.31 [2.25-4.86],1.0657357428983339e-09
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22517,3515,1.88 [1.76-2.01],8.134985588495704e-75
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21560,73,3.37 [2.26-5.04],2.9844104697763e-09
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22815,65,3.38 [2.27-5.03],2.2950557741394514e-09
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22772,1985,2.01 [1.84-2.19],6.9059420149283665e-56
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22770,1983,2.01 [1.84-2.19],7.69052527366735e-56
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20900,113,2.11 [1.46-3.07],7.965527204576665e-05
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22924,1437,1.90 [1.72-2.10],2.4637946625387287e-35
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22865,115,2.27 [1.63-3.17],1.2757797817039934e-06
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22664,74,3.30 [2.27-4.80],3.5469648400530165e-10
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22665,75,1.22 [0.75-1.96],0.4234005536002542
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23106,356,2.48 [2.06-2.98],9.31051217415799e-22
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23160,39,3.32 [2.05-5.37],9.709423506249108e-07
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23041,291,2.42 [1.97-2.97],6.178238923253937e-17
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21626,139,2.00 [1.45-2.77],2.8520539869388697e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15570,418,3.62 [3.07-4.26],3.3449516176612757e-54
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21774,102,1.39 [0.89-2.18],0.1491626387859442
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21782,110,1.13 [0.77-1.66],0.5298747125237022
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15223,71,1.73 [1.05-2.83],0.0300342930228218
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21629,64,1.92 [1.20-3.05],0.0062530821764002
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20834,321,1.57 [1.25-1.96],8.475318246478899e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22488,966,1.78 [1.57-2.02],2.1571664737380888e-19
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22005,483,1.07 [0.88-1.30],0.4939977451361844
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21741,219,0.67 [0.49-0.90],0.0086858669003911
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23003,1438,1.27 [1.14-1.41],1.8091742076107523e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19589,1393,1.31 [1.17-1.46],3.1749340880620586e-06
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15244,92,1.91 [1.25-2.92],0.0026594337074128
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20984,102,1.31 [0.86-1.98],0.2078378516983206
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15519,367,2.25 [1.83-2.76],6.9201492969536325e-15
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15207,55,1.61 [0.91-2.83],0.1020617890747107
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19786,4634,1.20 [1.13-1.28],1.7351438119429457e-08
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15420,268,2.44 [1.92-3.09],2.323664953188232e-13
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15864,712,1.98 [1.70-2.30],3.917329491538329e-19
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23229,370,2.21 [1.82-2.67],4.725915413824063e-16
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23020,161,3.55 [2.77-4.56],3.320174095433452e-23
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15308,156,1.56 [1.11-2.19],0.0104606275854851
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15235,83,3.44 [2.37-4.99],7.628667684300729e-11
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22646,1764,1.56 [1.42-1.72],3.0293771869563245e-20
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15539,387,4.19 [3.57-4.93],1.855593460899664e-67
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15578,426,4.39 [3.79-5.08],2.0208737413643e-87
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16026,874,1.30 [1.12-1.50],0.0005294501527834
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15331,179,2.12 [1.57-2.87],8.229725085232973e-07
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23010,151,3.60 [2.77-4.66],4.46475653438678e-22
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,16053,901,1.87 [1.64-2.14],6.813095978567511e-20
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15812,660,1.90 [1.63-2.23],1.4797071864758129e-15
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20594,81,3.00 [2.06-4.37],1.0629197445028083e-08
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21623,6471,1.34 [1.27-1.41],9.78352000711695e-28
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20942,60,2.04 [1.26-3.30],0.0037154613491896
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20931,49,1.97 [1.13-3.42],0.0164701707618281
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23101,1924,1.22 [1.11-1.34],2.722810358823085e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23099,1922,1.22 [1.11-1.34],3.235725483696082e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20948,66,1.88 [1.18-3.02],0.0084052253207844
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22932,1140,1.02 [0.89-1.15],0.8078437571118684
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17401,2249,2.16 [1.99-2.34],1.4148537846286354e-79
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23274,317,3.07 [2.57-3.68],2.300208586357929e-34
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21655,133,1.33 [0.93-1.89],0.1179372650556927
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21910,118,1.10 [0.75-1.63],0.6191922271365787
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21956,164,1.18 [0.85-1.64],0.3114063534191139
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15353,201,1.91 [1.43-2.56],1.3470173266863212e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20475,186,1.94 [1.48-2.54],1.527083229608308e-06
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2493,102,3.24 [2.33-4.51],2.379431298090672e-12
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2658,309,1.47 [1.18-1.83],0.0005758960046832
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20374,85,4.37 [3.14-6.08],1.9752310547323097e-18
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2465,77,6.13 [4.37-8.61],1.1021244313573128e-25
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22435,2146,1.24 [1.14-1.36],1.1936809948293829e-06
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22153,631,1.40 [1.19-1.64],5.018471689440461e-05
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20968,455,1.82 [1.52-2.19],1.3433237607535558e-10
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16277,1125,2.22 [1.98-2.50],6.436372663845587e-42
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23152,305,1.83 [1.47-2.27],5.8911411809964416e-08
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21779,274,1.80 [1.42-2.28],1.507013529069699e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Angina pectoris,20099,1579,1.40 [1.26-1.55],1.2413516692222282e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21885,380,1.78 [1.45-2.18],3.0509757626780113e-08
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21595,90,3.41 [2.39-4.87],1.3459732380976486e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21800,295,2.95 [2.40-3.63],6.4217732645609615e-25
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11785,2866,1.60 [1.48-1.73],5.326921036033956e-32
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,AV-block,17679,681,1.66 [1.41-1.94],3.651233799852657e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23205,579,1.46 [1.24-1.73],5.533854538248849e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,9183,264,3.62 [2.83-4.62],8.841552250845273e-25
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17200,202,1.76 [1.32-2.35],0.0001065222410784
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17108,110,2.53 [1.78-3.60],2.5173738034209985e-07
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23285,82,1.76 [1.15-2.68],0.0086851738511263
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Conduction disorders,18566,1568,1.64 [1.48-1.82],3.851075351719315e-21
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21274,2779,1.47 [1.36-1.59],3.8845352952265297e-23
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18687,8965,1.22 [1.17-1.28],9.46283357235582e-17
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21708,335,1.83 [1.48-2.26],2.2032211708457612e-08
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Endocarditis,17100,102,1.93 [1.30-2.89],0.0012403693930908
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22993,1678,2.05 [1.87-2.25],1.7303206883915704e-53
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypertension,19929,7976,1.24 [1.18-1.30],5.707074656022343e-17
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19948,7995,1.24 [1.18-1.31],3.809149396598482e-18
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23115,93,3.41 [2.44-4.76],7.395025190716496e-13
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12215,262,2.58 [2.06-3.23],2.1178342566011662e-16
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12164,211,7.25 [6.11-8.59],7.336500633314095e-115
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypotension,23104,1658,1.81 [1.64-1.99],7.2026785117219074e-34
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21984,153,1.10 [0.78-1.55],0.5950472192737832
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21450,2930,1.43 [1.33-1.54],7.243529606480574e-21
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22773,811,1.69 [1.48-1.94],4.132037032605432e-14
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17527,529,1.82 [1.53-2.16],2.3651958425274048e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22593,1070,1.53 [1.36-1.73],3.2207774030077923e-12
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19440,920,1.75 [1.54-2.00],2.1451514127475226e-17
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23158,191,1.38 [1.03-1.84],0.0304755096363884
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23246,414,1.69 [1.39-2.04],8.12805510401341e-08
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21438,65,2.62 [1.69-4.07],1.6802706373019064e-05
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other aneurysm,21611,106,1.95 [1.34-2.85],0.0005267180306241
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17599,601,1.55 [1.31-1.84],3.906485522428138e-07
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21644,139,3.54 [2.67-4.69],1.796350777022224e-18
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21840,335,2.09 [1.70-2.57],3.1522524520006638e-12
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17224,226,1.85 [1.42-2.42],6.661866330187284e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,21493,120,2.27 [1.62-3.18],1.977412671985393e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21420,47,1.26 [0.68-2.31],0.4624722443141501
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21207,93,1.32 [0.86-2.01],0.1984462072441452
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21553,180,1.33 [0.97-1.80],0.0727568265164267
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18473,1475,1.91 [1.72-2.11],2.0909789516790745e-35
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21509,63,3.27 [2.17-4.92],1.4840638117974126e-08
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22241,736,2.20 [1.92-2.52],2.2765238427576146e-29
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22511,532,2.19 [1.87-2.56],1.2677468012299242e-22
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22103,989,1.69 [1.49-1.91],3.29556826531883e-16
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9342,423,1.97 [1.59-2.45],5.870656287892722e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22070,601,2.59 [2.23-3.00],9.243469954272725e-37
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21798,425,1.62 [1.34-1.97],7.943727689512274e-07
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22587,608,1.67 [1.42-1.96],4.4154319989570855e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23187,978,1.87 [1.65-2.11],7.536080573506261e-24
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17517,519,1.75 [1.47-2.09],5.894657525645561e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22504,525,2.17 [1.85-2.54],8.053760387562257e-22
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21383,269,2.78 [2.25-3.43],1.4399955682155685e-21
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22757,926,1.56 [1.37-1.78],1.7369148588772448e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22742,966,1.55 [1.37-1.76],1.4195700873669159e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21951,63,0.97 [0.56-1.67],0.9011927180786572
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21612,107,1.96 [1.34-2.87],0.0005279207512471
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22287,325,1.32 [1.05-1.65],0.0172893115398983
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21860,337,1.55 [1.25-1.91],5.837195189720716e-05
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Varicose veins,21894,521,1.69 [1.43-2.01],2.317595677732263e-09
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21526,125,1.96 [1.38-2.79],0.0001852341356059
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23009,955,1.64 [1.44-1.86],3.955486950992028e-14
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23206,332,1.19 [0.95-1.49],0.1268137059212585
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19888,1390,1.08 [0.96-1.21],0.1906400002584743
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Any mental disorder,22750,4252,1.23 [1.15-1.31],3.005195605424017e-10
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23177,391,1.21 [0.98-1.48],0.0740330215932446
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19963,1465,1.31 [1.17-1.46],1.2761331929756772e-06
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18583,85,1.06 [0.66-1.68],0.8209165993165192
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Smoking dependency,22769,1183,1.42 [1.26-1.60],1.2838473173212028e-08
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19954,1456,1.36 [1.23-1.51],7.062592917798492e-09
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Vascular dementia,22384,235,1.38 [1.06-1.80],0.0154525922815995
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23286,592,1.06 [0.89-1.26],0.5185690960634535
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",14246,110,1.34 [0.88-2.03],0.1724141335664733
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Bell's palsy,21425,86,1.68 [1.10-2.55],0.0154444694818594
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21838,499,0.91 [0.75-1.11],0.3519233739891886
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Cerebral cysts,22832,254,1.77 [1.38-2.25],4.577501638117351e-06
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23211,415,2.03 [1.70-2.43],1.4467554249375737e-14
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22427,75,0.66 [0.40-1.10],0.1118529236026809
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23268,69,1.21 [0.74-1.98],0.4547050013405895
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22667,89,2.26 [1.53-3.33],3.788555517071093e-05
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Epilepsy,21764,308,1.30 [1.03-1.64],0.0291748063305149
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22821,1365,1.30 [1.17-1.46],2.528007874802264e-06
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23232,931,0.92 [0.80-1.06],0.2706366769287264
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22621,3485,1.38 [1.29-1.48],3.2430466667874755e-20
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,22902,54,1.05 [0.59-1.86],0.8692411030326724
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Hemiplegia,23135,339,2.37 [1.95-2.87],1.659748535352531e-18
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Hydrocephalus,22654,76,0.92 [0.56-1.51],0.7406202719794213
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23273,75,1.44 [0.91-2.28],0.1242392128278607
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21405,66,0.96 [0.57-1.65],0.8959248011247025
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21412,73,0.91 [0.56-1.50],0.7251284839212242
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Memory loss,22128,145,1.07 [0.75-1.52],0.7042833037007393
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Migraine,21739,283,1.27 [0.99-1.62],0.064341764221409
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23240,259,1.27 [0.98-1.64],0.0699028621279406
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Motor neuron disease,14337,177,1.00 [0.71-1.40],0.9935305581099944
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23155,63,1.04 [0.61-1.78],0.8875456845962819
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22574,1235,1.08 [0.96-1.22],0.1922162420929609
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Neurological diseases,21788,4390,1.20 [1.12-1.28],2.7796403471248824e-08
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22681,329,1.58 [1.28-1.97],2.944298998200949e-05
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21771,432,1.04 [0.85-1.27],0.7253974912838641
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23207,349,2.30 [1.90-2.79],9.268849589626164e-18
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17408,986,1.29 [1.13-1.47],0.0002272700952631
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22664,86,1.41 [0.92-2.18],0.1158171973207151
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22739,161,1.51 [1.11-2.05],0.0091849221629554
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22538,237,1.11 [0.85-1.46],0.4408284026286511
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21436,97,1.51 [1.01-2.27],0.0447558255377094
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other headache syndromes,21508,52,1.15 [0.64-2.06],0.6471485768892992
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23169,591,1.51 [1.28-1.78],6.641666445368018e-07
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other sleep disorders,21979,523,1.30 [1.09-1.55],0.0037322562731644
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23253,691,0.86 [0.73-1.01],0.0595740995462754
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22623,45,1.69 [0.94-3.05],0.0801005916810109
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23287,110,0.95 [0.63-1.43],0.7950668936261964
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23054,445,1.42 [1.17-1.71],0.0002800996426507
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22920,62,3.02 [1.99-4.60],2.485573545402913e-07
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23276,206,0.97 [0.72-1.31],0.8550839667132653
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21406,67,0.68 [0.40-1.18],0.1700471369523394
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23286,598,1.07 [0.90-1.27],0.424535589617305
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22322,229,1.44 [1.10-1.88],0.0070295094406353
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22632,156,1.23 [0.88-1.72],0.2168259768154019
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22827,570,1.03 [0.86-1.24],0.7114411151392138
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23029,268,1.58 [1.25-2.00],0.0001498403984635
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22047,68,0.92 [0.55-1.55],0.764592692513181
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22018,39,0.78 [0.39-1.57],0.4821703485251103
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23163,72,1.91 [1.22-2.98],0.0046853044108378
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22970,227,1.15 [0.87-1.52],0.3389747121401121
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2469,78,5.75 [4.11-8.03],1.267089969199974e-24
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3044,116,2.60 [1.95-3.46],6.058066831535591e-11
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22587,111,1.23 [0.83-1.82],0.3107044286192783
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22984,1440,1.23 [1.10-1.37],0.0002584331096203
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22870,891,1.04 [0.90-1.20],0.5748120232294749
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22284,305,1.08 [0.85-1.38],0.5144113255093173
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23211,954,0.93 [0.81-1.07],0.3226413702549923
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23280,83,1.18 [0.75-1.86],0.4769895509394548
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23136,879,0.94 [0.81-1.09],0.4160651365162829
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23243,500,1.11 [0.92-1.35],0.2666750714100269
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23165,229,1.37 [1.05-1.78],0.0221458577881006
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22079,100,1.37 [0.91-2.04],0.1275666905403906
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22081,102,0.91 [0.60-1.39],0.6678147630398755
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22055,76,0.81 [0.49-1.34],0.4132772497665337
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23153,1028,0.87 [0.76-0.99],0.0371744915078589
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22391,266,0.78 [0.60-1.02],0.0672163092224804
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22327,70,1.04 [0.63-1.73],0.8708904780296688
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22865,122,1.28 [0.88-1.86],0.1917384524087693
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23135,392,1.14 [0.92-1.41],0.2282764250203813
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22478,221,0.73 [0.54-0.98],0.0392669752591164
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23080,144,1.19 [0.84-1.68],0.3314337857900042
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22811,686,0.91 [0.77-1.07],0.2502207826514877
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22637,161,1.01 [0.72-1.41],0.946950836597062
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20811,3253,1.17 [1.08-1.26],3.728386928357612e-05
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23090,347,1.05 [0.84-1.32],0.6654847996997453
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23273,191,1.30 [0.97-1.75],0.0792948445280423
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22523,544,0.99 [0.82-1.18],0.8860649563186195
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22833,90,1.15 [0.74-1.78],0.5381751380880089
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23271,74,1.04 [0.64-1.70],0.867536132795993
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22109,130,1.15 [0.80-1.66],0.4444112700494023
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22157,178,0.91 [0.66-1.25],0.5674205223443866
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21710,166,1.43 [1.05-1.96],0.0251551375337098
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22321,64,0.86 [0.50-1.47],0.5771781044425609
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21619,75,0.59 [0.35-1.00],0.04879987783408
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22242,117,0.72 [0.48-1.08],0.1109135811938116
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22421,296,0.95 [0.74-1.21],0.6660498689739927
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22140,161,1.12 [0.81-1.56],0.4798196137766271
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21641,97,1.06 [0.69-1.64],0.780205263690505
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21679,135,1.34 [0.94-1.91],0.1083834042686632
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20319,2761,1.12 [1.03-1.22],0.0052895105877842
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22071,92,1.01 [0.65-1.56],0.9798032285564728
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22990,514,1.12 [0.94-1.35],0.2113794204828523
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22557,81,1.30 [0.83-2.03],0.2533547173028771
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22686,210,1.52 [1.15-2.00],0.0029670585925322
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23064,114,1.08 [0.72-1.61],0.7184731129960781
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23239,140,1.42 [1.02-1.99],0.0378668225941088
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23148,120,1.50 [1.05-2.14],0.0276976323041151
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23015,65,0.82 [0.48-1.41],0.4729535993618478
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23021,71,2.32 [1.51-3.56],0.0001162394701692
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23180,1259,1.38 [1.23-1.55],4.12335585742463e-08
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22874,953,1.41 [1.23-1.60],3.320505082596015e-07
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22074,153,1.52 [1.10-2.10],0.0107341120019612
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22012,91,0.68 [0.42-1.08],0.1017754975832446
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23093,66,2.30 [1.48-3.58],0.0002203962074342
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23214,187,1.60 [1.21-2.13],0.0011048272318031
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23091,64,1.87 [1.17-3.00],0.0088605234434959
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,All influenza,20590,157,2.87 [2.15-3.84],1.0268607718198932e-12
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20587,154,2.88 [2.15-3.86],1.4102272958131932e-12
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14356,101,1.15 [0.74-1.79],0.535180254721036
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23178,237,0.92 [0.70-1.22],0.5754215106451839
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15579,1717,1.26 [1.14-1.41],1.7348290267506554e-05
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15949,1694,1.25 [1.13-1.39],3.618180210950136e-05
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22768,178,2.10 [1.60-2.75],1.0047986048718505e-07
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20537,104,1.99 [1.37-2.91],0.0003526616865369
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Bronchiectasis,19536,519,1.89 [1.60-2.25],2.0969463175461717e-13
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19090,73,2.09 [1.33-3.28],0.0014233919945114
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22154,3137,1.36 [1.26-1.46],2.44872043165989e-16
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22058,73,0.85 [0.51-1.41],0.5308230797853464
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22119,134,0.70 [0.48-1.02],0.0663336147346593
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22992,1637,1.69 [1.54-1.87],1.138909377060928e-26
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22065,80,0.92 [0.57-1.48],0.7245158399930289
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21123,6141,1.44 [1.37-1.52],5.940241326214999e-42
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22319,334,1.07 [0.86-1.35],0.5387799253847035
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Early onset COPD,21465,110,1.97 [1.37-2.82],0.0002446362572169
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Emphysema,19455,438,2.20 [1.84-2.64],1.70991626873699e-17
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21978,454,1.98 [1.66-2.36],2.231734644377068e-14
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23027,2594,2.03 [1.88-2.19],2.296241469223408e-77
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22021,497,1.95 [1.65-2.31],6.760445887395173e-15
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Later onset COPD,22759,1527,1.69 [1.52-1.86],2.0806845434933523e-24
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23270,498,1.87 [1.58-2.21],4.106420402430778e-13
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Nasal polyp,22083,98,0.98 [0.64-1.49],0.9250262221107064
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23003,1309,1.75 [1.57-1.94],6.941457571838898e-25
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22995,2711,1.80 [1.67-1.94],1.6594163984627144e-53
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22736,751,0.99 [0.85-1.16],0.8971518289172584
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other pleural conditions,20352,68,1.67 [1.02-2.73],0.0404358374382677
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23166,595,2.07 [1.78-2.41],1.3824943264593613e-21
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23158,1729,1.80 [1.64-1.97],1.5887605720584818e-35
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pleural effusion,21663,1379,2.12 [1.91-2.35],5.00938014530622e-47
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pleural plaque,20538,254,1.88 [1.47-2.40],4.461686412377463e-07
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22742,2309,2.06 [1.91-2.23],9.59652734057708e-73
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23160,388,1.92 [1.59-2.33],1.923993244216412e-11
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pneumothorax,20455,171,1.65 [1.21-2.25],0.0015912430511943
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pollen allergy,23275,201,0.94 [0.69-1.27],0.6663333914121852
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,22663,92,3.20 [2.30-4.47],6.8889074414823146e-12
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14326,71,2.69 [1.72-4.22],1.611577012628355e-05
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22979,1285,1.75 [1.58-1.95],6.848749337350801e-25
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22224,239,0.93 [0.70-1.23],0.6133959285624531
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Viral pneumonia,20736,303,2.29 [1.83-2.85],2.049826193274809e-13
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22778,243,2.06 [1.62-2.62],4.365382839548006e-09
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7415,117,1.32 [0.86-2.02],0.2032286063186116
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14746,61,1.34 [0.78-2.29],0.2839592419489388
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23171,131,1.24 [0.86-1.77],0.2478368574457852
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute gastritis,16193,106,1.51 [1.02-2.24],0.0395138577820691
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21224,199,1.77 [1.35-2.33],3.816857429691678e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute peritonitis,22788,113,2.28 [1.63-3.21],1.951846180395927e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22300,64,2.49 [1.59-3.91],7.19974809466873e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,16599,512,1.45 [1.21-1.74],5.300215006915708e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21170,145,1.93 [1.41-2.65],4.721397555483688e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22860,145,1.85 [1.35-2.53],0.0001224412373099
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Cholecystitis,21248,223,1.35 [1.03-1.77],0.0289551956059854
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22086,1061,1.66 [1.47-1.88],1.2040718089739e-16
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Chronic gastritis,16437,350,1.39 [1.12-1.73],0.0034047501566309
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21080,55,1.17 [0.66-2.06],0.5873400762398677
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23149,127,3.23 [2.42-4.33],3.118763981749612e-15
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Coeliac disease,21523,127,1.67 [1.18-2.38],0.0041879487983824
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Collagenous colitis,21520,102,1.53 [1.02-2.30],0.0378323674882846
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23170,158,1.18 [0.86-1.64],0.3072828687399206
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Constipation,22999,2156,1.45 [1.33-1.58],8.151832426977016e-17
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Crohn disease,21507,89,2.86 [2.00-4.10],8.660947444807631e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22930,68,2.42 [1.59-3.69],4.094806007687058e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21499,81,2.74 [1.86-4.02],2.718780776290853e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Dental caries,22661,189,1.65 [1.25-2.19],0.0004750921610661
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20123,2581,1.28 [1.18-1.39],3.158045898832547e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23202,162,1.14 [0.82-1.59],0.4246948492981842
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of liver,23163,927,1.78 [1.57-2.02],4.414280913871845e-19
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20718,4631,1.28 [1.20-1.36],3.3026340416995577e-15
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22948,476,1.27 [1.05-1.53],0.0120744511792252
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23195,520,1.54 [1.29-1.83],1.2099568265285792e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22566,94,1.02 [0.66-1.57],0.9441224858032145
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22438,59,1.17 [0.68-2.01],0.5724382629525724
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22944,1548,1.46 [1.32-1.61],3.869193060825285e-13
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22456,97,1.55 [1.03-2.31],0.0338360658171834
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22556,1531,1.63 [1.47-1.80],1.4240816732082356e-21
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18481,3796,1.20 [1.12-1.28],3.778433541495366e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,16338,251,1.63 [1.27-2.10],0.0001167450635878
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23194,204,1.41 [1.07-1.86],0.0148183756680234
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23248,27,0.89 [0.39-2.04],0.7794138315702278
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22384,148,3.49 [2.68-4.53],7.376784135880538e-21
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14793,108,1.14 [0.76-1.72],0.5156145016779273
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16655,568,1.05 [0.88-1.26],0.5656534882186579
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastric ulcer,16519,432,1.60 [1.32-1.93],1.6027481717643137e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18773,2686,1.27 [1.18-1.38],4.6691065899197425e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16747,660,1.63 [1.39-1.90],5.852006614218652e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16804,8266,1.23 [1.17-1.29],2.3574250613658265e-17
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,GI-bleeding,22683,1287,1.49 [1.33-1.67],1.7070960026827109e-12
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22517,45,1.46 [0.81-2.64],0.2084152580436047
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15687,1194,1.20 [1.06-1.36],0.0041629304039711
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22306,70,2.66 [1.75-4.02],4.077070059147697e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Hernia,21214,3672,1.20 [1.12-1.28],3.8019700988707323e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Impacted teeth,23252,25,0.97 [0.41-2.30],0.9521704556483084
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Impaction of intestines,14763,78,1.68 [1.06-2.67],0.0286050217733719
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Inguinal hernia,18647,1105,1.10 [0.97-1.25],0.1328777363850711
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17668,126,1.13 [0.78-1.65],0.5207010256260658
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14802,117,1.57 [1.07-2.29],0.0205816519001164
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21542,146,1.52 [1.09-2.13],0.0146570915560216
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15200,515,1.26 [1.05-1.53],0.0157123727167326
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23255,344,1.56 [1.26-1.93],4.2323700951528864e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22208,790,1.61 [1.41-1.85],1.0085862326805525e-11
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22519,1101,1.58 [1.41-1.78],2.39427511335433e-14
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16306,219,1.61 [1.23-2.12],0.0006039439499524
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oesophagitis,16793,706,1.32 [1.13-1.54],0.0004968859187676
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23231,132,0.96 [0.66-1.39],0.814973505945202
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17628,86,1.64 [1.06-2.53],0.0253999699344105
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16082,1397,1.20 [1.07-1.34],0.0018010066030903
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21386,361,1.36 [1.10-1.69],0.0052027028744242
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21174,149,1.20 [0.86-1.69],0.2878487465428974
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16635,1950,1.27 [1.16-1.40],5.889367650691152e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,20947,6262,1.23 [1.17-1.30],1.1462699934818204e-14
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22414,206,0.95 [0.70-1.28],0.7173553599885643
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23003,767,1.72 [1.50-1.98],3.3724014042824813e-14
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16858,771,1.44 [1.24-1.67],1.294358962940576e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21241,216,2.24 [1.75-2.88],2.612293985489211e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23116,441,1.33 [1.09-1.62],0.0041845137477066
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17197,1110,1.68 [1.49-1.89],2.430466771988549e-17
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22700,1304,1.49 [1.34-1.67],1.0941280694316697e-12
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22652,180,1.30 [0.96-1.76],0.0854774329043314
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16886,2201,1.51 [1.39-1.65],7.813273394625057e-21
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18267,2180,1.36 [1.25-1.49],6.8971750990932625e-12
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22350,114,1.95 [1.37-2.78],0.000201394123276
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22387,969,1.58 [1.39-1.79],1.027098951912215e-12
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15139,454,1.57 [1.30-1.90],3.605222014405498e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23244,31,0.90 [0.41-1.95],0.7839674513465446
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15310,625,1.61 [1.37-1.89],9.709604152676812e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21555,159,1.69 [1.24-2.30],0.0009719421443868
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23274,54,1.04 [0.59-1.85],0.8878931930422281
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22464,104,1.12 [0.74-1.70],0.5800412910854349
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Toxic colitis,21499,81,1.62 [1.04-2.54],0.0332580588547024
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16427,340,1.40 [1.12-1.75],0.0027497835615632
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21589,171,1.93 [1.44-2.58],9.408062138738584e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21554,136,1.74 [1.25-2.43],0.001170424152334
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Umbilical hernia,17799,257,0.97 [0.75-1.27],0.8409237821711885
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14933,248,2.16 [1.68-2.76],1.2275899011202863e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Ventral hernia,17830,288,1.44 [1.13-1.83],0.002990283677534
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Volvulus,14780,95,1.53 [1.01-2.33],0.0472289849961417
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23181,432,1.15 [0.94-1.41],0.1636959064665168
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22918,66,2.35 [1.54-3.59],8.094896932076585e-05
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20712,170,0.86 [0.61-1.21],0.3783444958998272
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22654,832,2.07 [1.82-2.36],1.3218133955854622e-28
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21968,146,2.10 [1.55-2.84],1.7845141439459943e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21175,633,2.43 [2.10-2.82],7.8170237954791e-33
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22940,319,1.73 [1.40-2.16],6.928042681112052e-07
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23184,563,1.86 [1.59-2.19],3.226795223856505e-14
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22669,48,2.58 [1.56-4.27],0.000228286085966
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21679,3758,1.48 [1.39-1.58],7.582718515973015e-31
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22852,442,1.14 [0.94-1.39],0.1866122913062546
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22717,307,0.95 [0.75-1.22],0.7012512166602873
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22900,1078,1.94 [1.73-2.17],1.2360978122350196e-29
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23267,60,1.36 [0.81-2.30],0.2432899251697885
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20599,57,4.04 [2.69-6.08],1.8174889685405948e-11
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22473,63,2.04 [1.29-3.21],0.0022030773569322
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22926,305,1.70 [1.36-2.12],3.551926824049261e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21154,612,1.28 [1.08-1.52],0.0043352729034978
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20632,90,1.39 [0.89-2.15],0.1450289914220345
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23198,95,2.41 [1.67-3.48],2.662241668334197e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22052,230,2.38 [1.88-3.02],7.988590249727159e-13
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23079,227,1.36 [1.04-1.78],0.0231701568819209
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22719,98,2.76 [1.92-3.98],4.982199754713706e-08
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20622,80,1.33 [0.83-2.11],0.2370546614868347
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22671,2129,1.58 [1.45-1.72],2.0419547482169088e-25
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21201,659,1.35 [1.14-1.58],0.0003513349267611
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20636,94,1.40 [0.91-2.16],0.1233421294917233
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23194,342,1.40 [1.12-1.74],0.0027002783321424
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22696,75,1.69 [1.08-2.65],0.0225413393219062
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23131,279,1.40 [1.10-1.79],0.0057387280488745
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23213,464,1.10 [0.91-1.34],0.3365499896708871
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20668,126,0.85 [0.57-1.26],0.4067164297220876
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20880,338,0.92 [0.73-1.17],0.5071402095804257
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23201,452,1.14 [0.94-1.39],0.1794912094248034
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20883,341,3.13 [2.61-3.76],2.998077374395304e-34
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23258,155,1.95 [1.44-2.65],1.5381619296865882e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19405,82,1.10 [0.69-1.74],0.6962804295045587
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20520,6490,1.22 [1.16-1.29],1.5586292817648586e-13
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19099,5069,1.17 [1.10-1.24],3.05347396473354e-07
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19377,54,1.17 [0.66-2.06],0.5885671853784866
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19318,148,1.36 [0.97-1.90],0.0749040032881745
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19363,193,1.83 [1.39-2.42],1.755966060963555e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23020,65,1.52 [0.93-2.48],0.0952132587677503
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19319,149,1.70 [1.22-2.36],0.0015413237311769
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15526,1496,1.14 [1.02-1.27],0.0250022633342116
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23073,250,0.99 [0.76-1.30],0.9680430274795166
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19761,591,1.08 [0.91-1.29],0.3753817531048569
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18843,8092,1.19 [1.13-1.25],4.450850483346771e-12
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20730,121,1.31 [0.89-1.92],0.1670971909998978
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19509,186,1.80 [1.36-2.38],4.469467027830617e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19833,510,0.98 [0.81-1.19],0.8291127076057553
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22342,3172,1.19 [1.10-1.28],5.061552213635911e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19638,315,0.85 [0.67-1.09],0.1929948501106849
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19474,151,1.33 [0.94-1.88],0.1024215689240572
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19438,115,0.90 [0.60-1.35],0.613918345800157
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22532,102,1.14 [0.75-1.75],0.541215677578196
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16058,2028,1.11 [1.00-1.22],0.0397010109670607
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14837,807,2.50 [2.21-2.84],1.8326832657700083e-45
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23189,800,2.36 [2.08-2.68],2.873549043175701e-40
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14108,78,0.59 [0.35-0.99],0.04612810848478
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14332,302,1.29 [1.01-1.66],0.0414429904592771
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19594,271,0.91 [0.70-1.18],0.4678601384898543
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14517,487,0.92 [0.75-1.12],0.4104715330957651
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19252,82,2.17 [1.43-3.30],0.0002772857362674
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19862,692,1.31 [1.12-1.53],0.00074431099019
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19491,321,1.03 [0.81-1.31],0.8222186701214098
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14487,457,0.86 [0.70-1.07],0.1742766879116834
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19396,73,1.30 [0.80-2.10],0.2875451380546995
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19382,59,1.67 [1.01-2.78],0.0471764834307861
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20694,85,2.96 [2.04-4.30],1.2686156312022344e-08
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22852,2243,1.37 [1.25-1.49],2.3371265798733768e-12
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22177,1568,1.37 [1.23-1.52],4.213966123604003e-09
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23110,547,2.06 [1.75-2.42],3.4578112453505602e-18
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17184,3154,1.31 [1.21-1.41],4.755737537706468e-12
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14072,42,0.88 [0.44-1.77],0.7155858977075612
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19430,107,1.40 [0.94-2.07],0.0978683149477344
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14100,70,1.76 [1.07-2.89],0.0250932740028517
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14164,134,1.58 [1.10-2.27],0.0129093019074773
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20857,248,1.45 [1.11-1.88],0.0056869668297574
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21121,512,1.53 [1.27-1.84],5.545677722713441e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23263,114,1.47 [1.00-2.14],0.0473564958696827
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21172,2002,1.20 [1.09-1.31],0.0001913344215484
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19401,78,1.78 [1.15-2.75],0.0095638505103727
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14186,156,1.61 [1.16-2.25],0.0047771256914783
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19968,798,1.06 [0.91-1.24],0.429783971238854
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16233,2203,1.27 [1.16-1.39],3.6899005802620553e-07
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22557,127,1.53 [1.06-2.19],0.0223211260970233
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23275,63,2.44 [1.59-3.74],4.348853261377698e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19400,77,0.97 [0.59-1.57],0.8891498089122898
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20682,1359,1.51 [1.35-1.68],1.0618797272519397e-13
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19433,110,2.05 [1.43-2.93],9.35663606871372e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16123,2093,1.25 [1.14-1.37],3.51995728947736e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20729,120,1.35 [0.92-1.98],0.1223534806066532
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19361,38,0.99 [0.49-2.00],0.9708666855703516
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19366,196,1.16 [0.85-1.57],0.3454107784925703
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20012,689,1.85 [1.60-2.14],1.3727328194618628e-16
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22921,491,1.52 [1.27-1.83],6.6933600010715415e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19838,668,1.34 [1.15-1.58],0.0002751984787315
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23125,541,2.16 [1.84-2.54],8.56346037279164e-21
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23260,70,3.96 [2.79-5.63],1.7024294823009482e-14
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19493,170,1.17 [0.85-1.62],0.3315747704967134
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18118,896,1.56 [1.36-1.79],1.562234839770079e-10
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19974,651,1.44 [1.23-1.69],5.238021391792938e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19607,284,0.85 [0.66-1.10],0.2276480692513669
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14101,71,1.30 [0.78-2.17],0.3134617770026384
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17185,3155,1.44 [1.34-1.55],1.5150812339771491e-22
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14884,854,1.39 [1.21-1.61],7.255245422056487e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22806,376,1.10 [0.88-1.37],0.391213528329616
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23231,82,1.72 [1.12-2.66],0.0141264568719904
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20611,71,1.13 [0.70-1.82],0.6217014183023375
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14094,64,2.81 [1.81-4.36],3.857733196289091e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19281,111,1.18 [0.79-1.77],0.4170276798915667
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14585,555,2.21 [1.88-2.61],1.7349680963543993e-21
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19662,339,1.06 [0.84-1.33],0.6384286958714553
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19458,288,1.35 [1.06-1.72],0.014731278286417
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19436,266,1.11 [0.85-1.45],0.4381567952326947
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16365,68,1.33 [0.79-2.24],0.2836947282721859
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23265,75,3.94 [2.79-5.57],5.769989433737137e-15
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19884,561,1.06 [0.89-1.27],0.4988558948540285
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22522,92,3.52 [2.54-4.87],2.9880438904007414e-14
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21989,2666,1.25 [1.16-1.36],2.27602499861736e-08
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19472,149,1.37 [0.98-1.92],0.0665107769409361
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19892,722,1.22 [1.04-1.43],0.0121522672750465
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21903,275,1.10 [0.85-1.42],0.4855317930090347
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19430,260,0.83 [0.63-1.09],0.1778314277627007
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21198,2028,1.24 [1.13-1.36],5.981454684046369e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20499,1329,1.28 [1.15-1.44],1.7176578320662646e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19386,63,1.03 [0.60-1.77],0.914828616467234
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22548,118,3.90 [3.00-5.08],4.7979035902161024e-24
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19485,162,0.99 [0.71-1.38],0.9483426991237436
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19413,90,1.11 [0.71-1.74],0.6475194374178932
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14107,77,1.67 [1.05-2.68],0.0319744479733909
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21763,2267,3.29 [3.04-3.57],4.78645716870557e-191
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9313,26,0.64 [0.27-1.54],0.3240236655713399
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11815,34,0.91 [0.43-1.92],0.8001510760824193
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22955,311,1.33 [1.06-1.68],0.0138515680951978
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22749,105,1.52 [1.03-2.23],0.0343124374405178
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21843,2347,4.44 [4.13-4.77],0.0
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23050,135,7.65 [6.32-9.25],1.1961365772199313e-97
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22974,409,1.91 [1.57-2.31],3.885704239637987e-11
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Cystitis,19403,303,1.41 [1.11-1.79],0.0047651716175479
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Dialysis,19592,96,16.22 [12.78-20.59],5.649112368963163e-116
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10268,2163,1.12 [1.02-1.22],0.0146426503023108
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11916,135,1.27 [0.89-1.82],0.1858902264220646
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9327,40,0.76 [0.38-1.53],0.4443560541505396
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9875,588,1.12 [0.94-1.33],0.2062101951830957
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19181,6332,1.63 [1.55-1.72],3.1114375042716365e-71
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23014,99,6.47 [4.86-8.63],3.114809383444838e-37
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8222,117,0.84 [0.56-1.26],0.395804639155935
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19567,353,2.01 [1.60-2.53],2.350064529402201e-09
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9951,1846,1.12 [1.01-1.23],0.0241120909867156
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11982,161,0.79 [0.56-1.12],0.1945012507804291
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8232,127,1.25 [0.86-1.80],0.2361060129685303
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19188,88,1.52 [0.99-2.34],0.05626928875176
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10329,1042,1.15 [1.01-1.31],0.0315626775608934
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8165,60,1.79 [1.09-2.95],0.0208999956861414
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9326,39,1.30 [0.67-2.49],0.4376708651671811
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23272,89,1.37 [0.90-2.10],0.1467577889904478
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23275,86,1.17 [0.75-1.83],0.4793810099835977
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22082,2982,1.50 [1.40-1.62],1.8705591430826344e-27
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20048,948,1.25 [1.09-1.43],0.0015367696014362
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11832,51,1.40 [0.79-2.49],0.2450581105085356
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23200,635,2.29 [1.98-2.65],6.334791836003265e-29
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8258,153,1.28 [0.92-1.78],0.1461698692946903
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8265,160,1.39 [1.01-1.91],0.0437964333866996
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8256,151,1.09 [0.78-1.54],0.6045198551464284
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23245,86,1.33 [0.86-2.05],0.1987382688735545
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21472,2372,1.68 [1.54-1.82],8.440712492834824e-36
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11904,83,0.96 [0.60-1.54],0.8587931371841931
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9355,68,1.14 [0.68-1.90],0.6268793863548168
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9429,142,1.14 [0.80-1.62],0.4584226199098004
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9340,53,1.11 [0.62-1.99],0.7250102382060791
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9387,100,0.85 [0.55-1.32],0.4636278914855876
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19631,417,2.33 [1.90-2.86],5.48333630157378e-16
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22768,203,2.60 [2.03-3.34],6.510264238193046e-14
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9412,125,1.17 [0.81-1.71],0.400701496248332
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9312,25,1.43 [0.63-3.22],0.3928006839324471
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9497,210,0.99 [0.74-1.33],0.9537852037616796
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9380,93,1.73 [1.15-2.59],0.0078102998315709
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9494,207,1.18 [0.88-1.58],0.2647193276850877
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22963,48,3.12 [1.93-5.05],3.550034802156723e-06
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8261,156,1.34 [0.97-1.85],0.0802283430984625
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22991,3777,2.94 [2.76-3.13],3.3598448015442694e-246
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19310,96,4.03 [2.80-5.80],7.048191935294564e-14
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19676,180,6.56 [5.17-8.32],5.448425395897546e-54
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22683,39,1.37 [0.73-2.55],0.3276150968492098
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19372,272,1.76 [1.39-2.22],2.566918064208136e-06
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23041,397,1.30 [1.06-1.59],0.0128843569630048
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9324,37,1.05 [0.52-2.10],0.8910687858904449
